Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
- PMID: 17052657
- DOI: 10.1016/S1474-4422(06)70578-6
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
Abstract
Background: Several genes underlying rare monogenic forms of Parkinson's disease have been identified over the past decade. Despite evidence for a role for genetics in sporadic Parkinson's disease, few common genetic variants have been unequivocally linked to this disorder. We sought to identify any common genetic variability exerting a large effect in risk for Parkinson's disease in a population cohort and to produce publicly available genome-wide genotype data that can be openly mined by interested researchers and readily augmented by genotyping of additional repository subjects.
Methods: We did genome-wide, single-nucleotide-polymorphism (SNP) genotyping of publicly available samples from a cohort of Parkinson's disease patients (n=267) and neurologically normal controls (n=270). More than 408,000 unique SNPs were used from the Illumina Infinium I and HumanHap300 assays.
Findings: We have produced around 220 million genotypes in 537 participants. This raw genotype data has been and as such is the first publicly accessible high-density SNP data outside of the International HapMap Project. We also provide here the results of genotype and allele association tests.
Interpretation: We generated publicly available genotype data for Parkinson's disease patients and controls so that these data can be mined and augmented by other researchers to identify common genetic variability that results in minor and moderate risk for disease.
Comment in
-
Parkinson's disease genetics: a complex disease comes to the clinic.Lancet Neurol. 2006 Nov;5(11):896-7. doi: 10.1016/S1474-4422(06)70580-4. Lancet Neurol. 2006. PMID: 17052652 No abstract available.
Similar articles
-
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.Lancet Neurol. 2007 Apr;6(4):322-8. doi: 10.1016/S1474-4422(07)70037-6. Lancet Neurol. 2007. PMID: 17362836
-
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release.Lancet Neurol. 2007 May;6(5):414-20. doi: 10.1016/S1474-4422(07)70081-9. Lancet Neurol. 2007. PMID: 17434096 Free PMC article.
-
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Lancet Neurol. 2011. PMID: 21885347 Free PMC article.
-
Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system.Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220517. doi: 10.1098/rstb.2022.0517. Epub 2024 Feb 19. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38368938 Free PMC article. Review.
-
Genomics and bioinformatics of Parkinson's disease.Cold Spring Harb Perspect Med. 2012 Jul;2(7):a009449. doi: 10.1101/cshperspect.a009449. Cold Spring Harb Perspect Med. 2012. PMID: 22762024 Free PMC article. Review.
Cited by
-
Digenic Analysis Finds Highly Interactive Genetic Variants Underlying Polygenic Traits.Med Res Arch. 2023 Oct;11(10):10.18103/mra.v11i10.4604. doi: 10.18103/mra.v11i10.4604. Epub 2023 Oct 30. Med Res Arch. 2023. PMID: 38882238 Free PMC article.
-
Neuropathogenesis-on-chips for neurodegenerative diseases.Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8. Nat Commun. 2024. PMID: 38472255 Free PMC article. Review.
-
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease.Nat Genet. 2024 Jan;56(1):27-36. doi: 10.1038/s41588-023-01584-8. Epub 2023 Dec 28. Nat Genet. 2024. PMID: 38155330 Free PMC article.
-
A multi-threaded approach to genotype pattern mining for detecting digenic disease genes.Front Genet. 2023 Aug 24;14:1222517. doi: 10.3389/fgene.2023.1222517. eCollection 2023. Front Genet. 2023. PMID: 37693313 Free PMC article.
-
C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson's Disease.Int J Mol Sci. 2023 Jan 11;24(2):1459. doi: 10.3390/ijms24021459. Int J Mol Sci. 2023. PMID: 36674978 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous